<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32852032</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>222</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>13</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Induction of the Coxsackievirus and Adenovirus Receptor in Macrophages During the Formation of Atherosclerotic Plaques.</ArticleTitle><Pagination><StartPage>2041</StartPage><EndPage>2051</EndPage><MedlinePgn>2041-2051</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiaa418</ELocationID><Abstract><AbstractText>Multiple viruses are implicated in atherosclerosis, but the mechanisms by which they infect cells and contribute to plaque formation in arterial walls are not well understood. Based on reports showing the presence of enterovirus in atherosclerotic plaques we hypothesized that the coxsackievirus and adenovirus receptor (CXADR/CAR), although absent in normal arteries, could be induced during plaque formation. Large-scale microarray and mass spectrometric analyses revealed significant up-regulation of CXADR messenger RNA and protein levels in plaque-invested carotid arteries compared with control arteries. Macrophages were identified as a previously unknown cellular source of CXADR in human plaques and plaques from Ldr-/-Apob100/100 mice. CXADR was specifically associated with M1-polarized macrophages and foam cells and was experimentally induced during macrophage differentiation. Furthermore, it was significantly correlated with receptors for other viruses linked to atherosclerosis. The results show that CXADR is induced in macrophages during plaque formation, suggesting a mechanism by which enterovirus infect cells in atherosclerotic plaques.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nilchian</LastName><ForeName>Azadeh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plant</LastName><ForeName>Estelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parniewska</LastName><ForeName>Malgorzata M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santiago</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossignoli</LastName><ForeName>Ar&#xe1;nzazu</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skogsberg</LastName><ForeName>Josefin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedin</LastName><ForeName>Ulf</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matic</LastName><ForeName>Ljubica</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuxe</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568771">CLMP protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062727">Coxsackie and Adenovirus Receptor-Like Membrane Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002339" MajorTopicYN="N">Carotid Arteries</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062727" MajorTopicYN="N">Coxsackie and Adenovirus Receptor-Like Membrane Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058226" MajorTopicYN="N">Plaque, Atherosclerotic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CXADR/CAR</Keyword><Keyword MajorTopicYN="N">atherosclerosis</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">macrophages</Keyword><Keyword MajorTopicYN="N">virus receptors</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>7</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32852032</ArticleId><ArticleId IdType="pmc">PMC7661765</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiaa418</ArticleId><ArticleId IdType="pii">5869873</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54:2129&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2834169</ArticleId><ArticleId IdType="pubmed">19942084</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenfeld ME, Campbell LA. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 2011; 106:858&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">22012133</ArticleId></ArticleIdList></Reference><Reference><Citation>Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med 2019; 380:171&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30625066</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 148:335&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2184908</ArticleId><ArticleId IdType="pubmed">209124</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell LA, Rosenfeld ME. Infection and atherosclerosis development. Arch Med Res 2015; 46:339&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524506</ArticleId><ArticleId IdType="pubmed">26004263</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessa R, Pietro MD, Filardo S, Turriziani O. Infectious burden and atherosclerosis: a clinical issue. World J Clin Cases 2014; 2:240&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4097149</ArticleId><ArticleId IdType="pubmed">25032197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon TW, Kim DK, Ye JS, et al. &#xa0;Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas. J Microbiol 2004; 42:299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">15650686</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen M, Alfthan G, Jousilahti P, Kimpim&#xe4;ki M, Hovi T, Tuomilehto J. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation 1998; 98:2534&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9843459</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls AC, Thomas M. Coxsackie virus infection in acute myocardial infarction. Lancet 1977; 1:883&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">67289</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotkin VIa, Voronel&#x2019; VL, Timoshina MA, Zaripova ZA, Murina EA, Khromov-Borisov NN. Enterovirus infection as a risk factor of acute coronary syndrome and its complications [in Russian]. Klin Med (Mosk) 2011; 89:25&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21574437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilb&#xe4;ck NG, Mohammed A, Fohlman J, Friman G. Cardiovascular lipid accumulation with coxsackie B virus infection in mice. Am J Pathol 1990; 136:159&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1877460</ArticleId><ArticleId IdType="pubmed">2153346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergelson JM, Cunningham JA, Droguett G, et al. &#xa0;Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275:1320&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">9036860</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CB, Bergelson JM. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 2005; 57:869&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">15820557</ArticleId></ArticleIdList></Reference><Reference><Citation>Raschperger E, Thyberg J, Pettersson S, Philipson L, Fuxe J, Pettersson RF. The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. Exp Cell Res 2006; 312:1566&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16542650</ArticleId></ArticleIdList></Reference><Reference><Citation>Asher DR, Cerny AM, Weiler SR, et al. &#xa0;Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development. Genesis 2005; 42:77&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">15864812</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilchian A, Johansson J, Ghalali A, et al. &#xa0;CXADR-mediated formation of an AKT inhibitory signalosome at tight junctions controls epithelial-mesenchymal plasticity in breast cancer. Cancer Res 2019; 79:47&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">30385615</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent T, Neve EP, Johnson JR, et al. &#xa0;A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF- &#x3b2; mediated epithelial-mesenchymal transition. Nat Cell Biol 2009; 11:943&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3769970</ArticleId><ArticleId IdType="pubmed">19597490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Zapater E, Santis G, Parsons M. CAR: A key regulator of adhesion and inflammation. Int J Biochem Cell Biol 2017; 89:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28545889</ArticleId></ArticleIdList></Reference><Reference><Citation>Naylor AR, Rothwell PM, Bell PR. Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis. Eur J Vasc Endovasc Surg 2003; 26:115&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">12917824</ArticleId></ArticleIdList></Reference><Reference><Citation>Perisic L, Aldi S, Sun Y, et al. &#xa0;Gene expression signatures, pathways and networks in carotid atherosclerosis. J Intern Med 2016; 279:293&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">26620734</ArticleId></ArticleIdList></Reference><Reference><Citation>Matic LP, Jesus Iglesias M, Vesterlund M, et al. &#xa0;Novel multiomics profiling of human carotid atherosclerotic plaques and plasma reveals biliverdin reductase B as a marker of intraplaque hemorrhage. JACC Basic Transl Sci 2018; 3:464&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6115646</ArticleId><ArticleId IdType="pubmed">30175270</ArticleId></ArticleIdList></Reference><Reference><Citation>Perisic L, Hedin E, Razuvaev A, et al. &#xa0;Profiling of atherosclerotic lesions by gene and tissue microarrays reveals PCSK6 as a novel protease in unstable carotid atherosclerosis. Arterioscler Thromb Vasc Biol 2013; 33:2432&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">23908247</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe5;gs&#xe4;ter D, Zhu C, Bj&#xf6;rkegren J, Skogsberg J, Eriksson P. MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr-/-Apob100/100 mouse. Int J Mol Med 2011; 28:247&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21567073</ArticleId></ArticleIdList></Reference><Reference><Citation>Skogsberg J, Lundstr&#xf6;m J, Kovacs A, et al. &#xa0;Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet 2008; 4:e1000036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265530</ArticleId><ArticleId IdType="pubmed">18369455</ArticleId></ArticleIdList></Reference><Reference><Citation>Koltsova EK, Hedrick CC, Ley K. Myeloid cells in atherosclerosis: a delicate balance of anti-inflammatory and proinflammatory mechanisms. Curr Opin Lipidol 2013; 24:371&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4939820</ArticleId><ArticleId IdType="pubmed">24005215</ArticleId></ArticleIdList></Reference><Reference><Citation>Peled M, Fisher EA. Dynamic aspects of macrophage polarization during atherosclerosis progression and regression. Front Immunol 2014; 5:579.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4228913</ArticleId><ArticleId IdType="pubmed">25429291</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho HJ, Shashkin P, Gleissner CA, et al. &#xa0;Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics 2007; 29:149&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17244792</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham TH, Benner C, Lichtinger M, et al. &#xa0;Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 2012; 119:e161&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">22550342</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman SM, Baquero KC, Choudhury M, et al. &#xa0;C/EBP&#x3b2; in bone marrow is essential for diet induced inflammation, cholesterol balance, and atherosclerosis. Atherosclerosis 2016; 250:172&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4907836</ArticleId><ArticleId IdType="pubmed">27072340</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SR. Haematopoietic-expressed C/EBP&#x3b2;: a novel transcriptional regulator of hepatic liver metabolism and macrophage foam cells during atherosclerosis? Atherosclerosis 2016; 250:183&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">27207261</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinska A, Azari BM, Salifu MO, et al. &#xa0;The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb Haemost 2007; 97:272&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">17264957</ArticleId></ArticleIdList></Reference><Reference><Citation>Iiyama K, Hajra L, Iiyama M, et al. &#xa0;Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999; 85:199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">10417402</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourdillon MC, Poston RN, Covacho C, Chignier E, Bricca G, McGregor JL. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE-/-/ICAM-1-/-) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol 2000; 20:2630&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">11116064</ArticleId></ArticleIdList></Reference><Reference><Citation>Greve JM, Davis G, Meyer AM, et al. &#xa0;The major human rhinovirus receptor is ICAM-1. Cell 1989; 56:839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">2538243</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackburn R, Zhao H, Pebody R, Hayward A, Warren-Gash C. Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004&#x2013;2015. Clin Infect Dis 2018; 67:8&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6005111</ArticleId><ArticleId IdType="pubmed">29324996</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KL, Maguire JJ, Davenport AP. Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol 2011; 162:1453&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3057285</ArticleId><ArticleId IdType="pubmed">21133894</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Huang H. Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells. Exp Ther Med 2017; 14:4579&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5658766</ArticleId><ArticleId IdType="pubmed">29104665</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukamoto K, Kinoshita M, Kojima K, et al. &#xa0;Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progression to foam cells from macrophages. J Atheroscler Thromb 2002; 9:57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">12238639</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham TH, Langmann S, Schwarzfischer L, et al. &#xa0;CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation. J Biol Chem 2007; 282:21924&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">17540774</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson J, Berg T, Kurzejamska E, et al. &#xa0;MiR-155-mediated loss of C/EBP&#x3b2; shifts the TGF-&#x3b2; response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene 2013; 32:5614&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3898103</ArticleId><ArticleId IdType="pubmed">23955085</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankman LS, Gomez D, Cherepanova OA, et al. &#xa0;KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 2015; 21:628&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552085</ArticleId><ArticleId IdType="pubmed">25985364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chistiakov DA, Orekhov AN, Bobryshev YV. Endothelial barrier and its abnormalities in cardiovascular disease. Front Physiol 2015; 6:365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4673665</ArticleId><ArticleId IdType="pubmed">26696899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosati M, Valentin A, Patenaude DJ, Pavlakis GN. CCAAT-enhancer-binding protein beta (C/EBP beta) activates CCR5 promoter: increased C/EBP beta and CCR5 in T lymphocytes from HIV-1-infected individuals. J Immunol 2001; 167:1654&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11466389</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 1998; 72:4962&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110058</ArticleId><ArticleId IdType="pubmed">9573265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmat N, Ebadi A, Badalzadeh R, Memar MY, Baghi HB. Viral infection and atherosclerosis. Eur J Clin Microbiol Infect Dis 2018; 37:2225&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">30187247</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng JJ, Li JR, Huang MH, et al. &#xa0;CD36 is a co-receptor for hepatitis C virus E1 protein attachment. Sci Rep 2016; 6:21808.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4761891</ArticleId><ArticleId IdType="pubmed">26898231</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996; 87:2020&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8634453</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao L, Zou C, Shao P, Schaack J, Johnson PF, Shao J. Transcriptional regulation of fatty acid translocase/CD36 expression by CCAAT/enhancer-binding protein alpha. J Biol Chem 2008; 283:8788&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2276366</ArticleId><ArticleId IdType="pubmed">18263877</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Liao J, Aloor J, et al. &#xa0;CD11b/CD18 (Mac-1) is a novel surface receptor for extracellular double-stranded RNA to mediate cellular inflammatory responses. J Immunol 2013; 190:115&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3529770</ArticleId><ArticleId IdType="pubmed">23209319</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Martin N, Marcandalli J, Huang CS, et al. &#xa0;An unbiased screen for human cytomegalovirus identifies neuropilin-2 as a central viral receptor. Cell 2018; 174:1158&#x2013;71e19.</Citation><ArticleIdList><ArticleId IdType="pubmed">30057110</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>